InMode

39 articles with InMode

• InMode Reports First Quarter 2021 Financial Results: Quarterly Revenues of $65.5 Million Represent 62% Year over Year Growth. GAAP Earnings per Share of $0.63, 320% Year over Year Growth

  5/5/2021

  InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced consolidated financial results for its first quarter ended March 31, 2021 .

• InMode Expects First Quarter 2021 Revenue Between $65.0-$65.4M, Non-GAAP Earnings per Diluted Share Between $0.65-$0.67

  4/12/2021

   InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the first quarter 2021 before the Nasdaq market opens on Wednesday, May 5, 2021 .

• InMode Files ITC Complaint Against ILOODA and its U.S. Distributor, Cutera

  3/16/2021

  InMode Ltd., a leading global provider of innovative medical technologies, has filed a complaint with the United States International Trade Commission alleging ILOODA's SecretRF fractional radio frequency microneedling system, distributed in the United States by Cutera, Inc., infringes U.S. Patent No. 10,799,285.

• InMode Reports Record Fourth Quarter and Full Year 2020 Financial Results; Quarterly Revenues of $75.2 Million Represent 60% Year over Year Growth

  2/10/2021

  InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced consolidated financial results for its fourth quarter and full year ended December 31, 2020 .

• InMode Expects Record Fourth Quarter and Full Year 2020 Results, Fourth Quarter Revenue Between $74.5-$75M, Non-GAAP Earnings per Diluted Share Between $0.91-$0.93; Announces 2021 Full Year Revenue Guidance of $250- $260M

  1/12/2021

  InMode Ltd., a leading global provider of innovative medical technologies, announced that it expects to release its financial results for the fourth quarter and full year 2020 before the Nasdaq market opens on Wednesday, February 10, 2021.

• InMode to Participate at the 2021 ICR Conference

  1/11/2021

  - InMode Ltd. (Nasdaq:  INMD ), a leading global provider of innovative medical technologies, today announced its participation in the 2021 ICR Conference, which is being held virtually January 11-14, 2021 .

• InMode Announces Corporate Social Responsibility Strategy

  1/6/2021

  InMode Ltd., a leading global provider of innovative medical technologies, announced it will present a corporate social responsibility strategy in its annual 20-F filing, to report the Company's sustainable practices as it continues to expand into new communities and markets.

• InMode Reports Record Third Quarter 2020 Financial Results; Quarterly Revenues of $59.7 Million Represent 49% Year over Year Growth, GAAP and *Non-GAAP Diluted Earnings per Share of $0.57 and $0.63

  11/12/2020

  InMode Ltd., a leading global provider of innovative medical technologies, announced consolidated financial results for its third quarter ended September 30, 2020.

• InMode Announces US Patent for Fractional RF (Morpheus8)

  11/11/2020

  InMode Ltd., a leading global provider of innovative medical technologies, is pleased to announce that the US Patent and Trademark Office has granted to InMode Patent No. 10.799.285 covering its Morphues8 full body fractional radiofrequency technology.

• InMode Expects Record Third Quarter Results, Revenues Between $59.2-$59.5M, Non-GAAP Earnings per Diluted Share Between $0.60-$0.62; Increasing Full Year 2020 Revenue Guidance to $192-$195M

  10/13/2020

  InMode Ltd. (Nasdaq:  INMD ), a leading global provider of innovative medical technologies, announced today that it will release its financial results for the third quarter 2020 before the Nasdaq market opens on T

• InMode Reports Second Quarter 2020 Financial Results; Quarterly Revenues of $30.8 Million, GAAP and *Non-GAAP Diluted Earnings per Share of $0.21 and $0.24

  8/5/2020

  InMode Ltd., a leading global provider of innovative medical technologies, announced consolidated financial results for its second quarter ended June 30, 2020.

• InMode to Present at Upcoming Virtual Conferences in August

  8/3/2020

   InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that Moshe Mizrahy , Chairman and Chief Executive Officer, Dr. Michael Kreindel , co-founder and Chief Technology Officer, Yair Malca , Chief Financial Officer, Dr. Spero Theodorou , Chief Medical Officer, and Shakil Lakhan

• InMode Announces NMPA (formerly CFDA) Approval for Two InMode Platforms in China

  7/6/2020

  InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to announce that it has received clearance from the China National Medical Products Administration NMPA - (previously known as CFDA) for two proprietary InMode radiofrequency platforms - the InMode RF platform and the InMode

• InMode Receives Health Canada Certification for Evolve Tone

  6/16/2020

  InMode Ltd., a leading global provider of innovative medical technologies, is proud to announce Health Canada certification of Evolve Tone.

• InMode to Participate at Upcoming Virtual Investor Conferences

  5/11/2020

  InMode Ltd., a leading global provider of innovative medical technologies, announced that management is scheduled to participate at the following virtual investor conferences:

• InMode Reports First Quarter 2020 Financial Results; Quarterly Revenues of $40.4 Million Represent 32% Year over Year Growth

  5/6/2020

  InMode Ltd., a leading global provider of innovative medical technologies, announced financial results for its first quarter ended March 31, 2020.

• InMode Provides COVID-19 Business Update

  3/23/2020

  InMode Ltd. today provided an update regarding its business activities in light of the ongoing global health situation caused by the COVID-19. As of today, InMode's Q1 2020 revenue from devices and consumables is in line with its target. Based

• InMode Receives Health Canada Certification for Evoke

  2/24/2020

  LAKE FOREST, California , Feb. 24, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq:  INMD ) ("InMode"), a leading global provider of innovative medical technologies, has received Health Canada certification for Evoke, a breakthrough aesthetic solution for treating wrinkles and rhytids. Evoke is the first and only hands-free device designed

• InMode Reports Record Fourth Quarter and Full Year 2019 Financial Results

  2/18/2020

  InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced financial results for the fourth quarter and full year ended December 31, 2019.

• InMode to Present at Canaccord Genuity MedTech & Diagnostics Forum

  11/12/2019

  InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, announced today that Moshe Mizrahy, Chairman and Chief Executive Officer, will present at the Canaccord Genuity MedTech & Diagnostics Forum at the Westin Grand Central, New York City on November 21st at 11:30 am EST.